Elective total hip replacement: incidence, emergency readmission rate, and postoperative mortality.
about
Direct factor Xa inhibitors versus low molecular weight heparins or vitamin K antagonists for prevention of venous thromboembolism in elective primary hip or knee replacement or hip fracture repairDirect thrombin inhibitors versus vitamin K antagonists or low molecular weight heparins for prevention of venous thromboembolism following total hip or knee replacementDirect thrombin inhibitors versus vitamin K antagonists or low molecular weight heparin for prevention of venous thromboembolism following total hip or knee replacement or hip repairPatient survival after total knee arthroplasty. 5-year data in 926 patients.Cause-specific mortality: understanding uncertain tips of the disease iceberg.Prevalence of total hip replacement: how much demand has been met?Enhanced recovery program for hip and knee replacement reduces death rate.Apixaban and rivaroxaban safety after hip and knee arthroplasty: a meta-analysis.International variation in hip replacement rates.Disability in adults with hip and knee arthroplasty: a French national community based surveySocioeconomic differences in childhood hospital inpatient service utilisation and costs: prospective cohort studyNew oral antithrombotics: focus on dabigatran, an oral, reversible direct thrombin inhibitor for the prevention and treatment of venous and arterial thromboembolic disordersTime trends and demography of mortality after fractured neck of femur in an English population, 1968-98: database studyLong-term survival analysis of total hip replacement.Measures of early postoperative mortality: beyond hospital fatality ratesOrthopaedic and trauma surgeryReadmission rates in the state of Florida: a reflection of quality?Dabigatran etexilate for the prophylaxis of venous thromboembolism after hip or knee replacement rationale for dose regimen.Prevention and treatment of thromboembolic events in medical patients and new anticoagulants.New anticoagulants for the prevention of venous thromboembolism.A benefit-risk assessment of dabigatran in the prevention of venous thromboembolism in orthopaedic surgery.Preoperative versus postoperative initiation of thromboprophylaxis following major orthopedic surgery: safety and efficacy of postoperative administration supported by recent trials of new oral anticoagulantsOutcome of total hip replacement in Japan and England. Comparison of two retrospective cohorts.Intrathecal opioid versus ultrasound guided fascia iliaca plane block for analgesia after primary hip arthroplasty: study protocol for a randomised, blinded, noninferiority controlled trial.Thromboprophylaxis in hip arthroplasty. New frontiers and future strategy.Total hip replacement: the way forward.Current UK opinion on thromboprophylaxis in orthopaedic surgery: its use in routine total hip and knee arthroplasty.Rationale and design of XAMOS: noninterventional study of rivaroxaban for prophylaxis of venous thromboembolism after major hip and knee surgeryIncidence of disease after vasectomy: a record linkage retrospective cohort study.Low-molecular-weight heparin prophylaxis against thromboembolism after total hip replacement--the never-ending story?Impact of the CCR5 gene polymorphism on the survival of metastatic melanoma patients receiving immunotherapy.Early death following primary total hip arthroplasty: 1,727 procedures with mechanical thrombo-prophylaxis.Clinical effectiveness and cost-effectiveness of 2 management strategies for infected total hip arthroplasty in the elderly.Hospital- and patient-related characteristics determining length of hospital stay for hip and knee replacements.Peri-operative silent myocardial ischaemia in patients undergoing lower limb joint replacement surgery: an indicator of postoperative morbidity or mortality?PROPHYLAXIS OF VENOUS THROMBOEMBOLISM IN ORTHOPAEDIC SURGERY.Prolonged outpatient vitamin K antagonist use and risk of venous thromboembolism in patients undergoing total hip or knee replacement
P2860
Q24187415-AD24A6DE-4772-42DB-8AC3-6D1C0009BEBCQ24235993-5280F151-C4BA-4EBD-8828-3B813CFF09B3Q24244149-501DC4A8-A833-4A36-9A99-D390095CC5C1Q32077357-9C77739B-B683-4114-AF5E-11F6AF46012DQ33702134-CBBD1EFE-314A-4862-9B49-EAC821E3743DQ33702354-2F07F8BC-2967-47EF-A63E-47D442F34620Q34028412-EAD92F0E-19CB-4355-97FB-0BC216CF7194Q34088870-56E9E455-069B-4D96-B735-334148BF8FE9Q35069065-4C4B38AB-9EF4-412A-998A-1F1B8E45DAB3Q35553016-06754F35-EF87-4B66-ABAF-C770890BDEF8Q35559445-7765297C-651D-406A-8D72-5EA90C54E890Q35739671-047A5B40-9EB2-4EB5-873C-F7A7FC551C30Q36275502-4E8E7309-5974-484E-A403-A1DBC48F44ECQ36821189-B9676DC3-520F-42B9-825B-8A0586ECAADEQ36887456-13152CE0-115E-4D92-B6D4-D8FDADF6C6A8Q36903061-16CE1BAC-1147-4A86-A1A4-DBD3475200FBQ37303412-05E88A62-8013-48A3-AE3A-6A181210BEA5Q37583245-C00AF0B6-C4A4-402E-8234-FB2FCC542B5DQ37681486-81997E94-0577-4DDB-BE8A-83156920666FQ37763535-E00161FE-DDFF-4B44-9324-D0539516B59FQ37876398-B7487179-BBFD-4B49-89D6-1B08D2EE3785Q37956637-3F759503-2A22-4B13-8087-D3CA75FB041DQ39093768-11BAFF86-B0FC-46F2-BA10-8F2FB43C807CQ39270796-4E36BEEF-C1F6-46B0-ACF8-5BF94BFCE07FQ40837295-54BEF7A0-D4F1-43FF-A749-38F06A2C7B32Q41014231-3D592A36-B999-401C-AA13-EDF7658E77C8Q41590018-36CC8576-132E-4BDD-8188-8D3C7CA8D10CQ42198767-2FC44273-586C-4B5D-B45D-8E0AA9BDA384Q42263191-FA78C567-4AD0-4B94-A9B4-6DA577D2343CQ43617256-822AA535-0D9D-43FE-8040-DB43707C473DQ44319954-B0A16BB6-C498-41FD-BF98-764EFB3AEB5BQ44640295-F2BA1FAD-0241-4B80-AC53-A351758F616BQ50670041-40E24541-BF88-4645-9495-932BCA593B84Q51023024-AD369AC9-1E6A-45F8-8C47-98215C00DB18Q51455912-46C96686-9FB9-43B0-A742-E02AC4C2A840Q55061115-9BCA9F4E-D0C9-496F-B762-A12FD1DFEA6BQ57086698-DAA9B258-5355-40AB-933C-F3BC0CD267E0
P2860
Elective total hip replacement: incidence, emergency readmission rate, and postoperative mortality.
description
1991 nî lūn-bûn
@nan
1991 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1991 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
1991年の論文
@ja
1991年論文
@yue
1991年論文
@zh-hant
1991年論文
@zh-hk
1991年論文
@zh-mo
1991年論文
@zh-tw
1991年论文
@wuu
name
Elective total hip replacement ...... , and postoperative mortality.
@ast
Elective total hip replacement ...... , and postoperative mortality.
@en
type
label
Elective total hip replacement ...... , and postoperative mortality.
@ast
Elective total hip replacement ...... , and postoperative mortality.
@en
prefLabel
Elective total hip replacement ...... , and postoperative mortality.
@ast
Elective total hip replacement ...... , and postoperative mortality.
@en
P2093
P2860
P1433
P1476
Elective total hip replacement ...... , and postoperative mortality.
@en
P2093
P2860
P304
P356
10.1136/BMJ.303.6815.1431
P407
P577
1991-12-01T00:00:00Z